Pet Heart Rhythm Monitors Market Report 2026

The pet heart rhythm monitors market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising global pet ownership, increasing prevalence of animal cardiac disorders, limited access to advanced veterinary diagnostics in rural regions, high cost of traditional veterinary ECG systems, low awareness of preventive pet heart health monitoring.

The pet heart rhythm monitors market size is expected to see strong growth in the next few years. It will grow to $2.18 billion by 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing spending on preventive veterinary healthcare, expansion of pet insurance penetration worldwide, rising demand for home based animal monitoring solutions, growing geriatric pet population requiring cardiac care, stronger emphasis on early diagnosis of chronic animal diseases. Major trends in the forecast period include ultra lightweight pet wearable comfort design evolution, multi species anatomical adaptive sensor design, long duration battery optimization using low power hardware engineering, increased preventive veterinary cardiac screening awareness programs, cost effective consumer grade pet heart monitoring device expansion.

The increasing pet ownership is expected to drive the growth of the pet heart rhythm monitors market going forward. Pet ownership refers to the practice of keeping and caring for animals such as dogs, cats, or other pets within a household, reflecting both companionship and responsibility for their well-being. The rise in pet ownership is driven by increased companionship and emotional support, as pets enhance well-being and align with modern lifestyles. Pet heart rhythm monitors support pet ownership by enabling continuous cardiac monitoring, allowing owners and veterinarians to detect heart-related issues at an early stage and ensure pets remain healthy and active. For instance, in March 2025, according to the American Pet Products Association, a US-based trade association, pet ownership in the US rebounded, with 94 million households owning at least one pet, up from 82 million in 2023, and 51% having a dog and 37% having a cat. Therefore, the increasing pet ownership is expected to drive the growth of the pet heart rhythm monitors market.

Leading companies operating in the pet heart rhythm monitors market are focusing on developing advanced solutions, such as continuous resting heart rate monitoring, to enhance early detection of cardiac irregularities, improve pet health management, and prevent serious cardiovascular events. Continuous resting heart rate monitoring refers to the ongoing tracking of a pet’s heart rate while at rest to detect abnormalities and assess overall cardiac health. for example, in May 2025, Tractive, an Austria-based technology company launched its next-generation Tractive Health Monitor, a wearable device designed to continuously track resting heart rate and activity levels in cats and dogs. The solution allows pet owners and veterinarians to detect abnormal heart rhythms early, monitor long-term cardiovascular health, and make informed decisions to prevent serious and costly health issues, supporting proactive pet care.

In December 2024, PetPace, a US-based provider of non-invasive smart collars, partnered with TelmyVet to transform the pet care industry in Canada. Through this collaboration, PetPace and TelmyVet aim to deliver veterinarians and pet owners across Canada an AI-driven health monitoring collar integrated with a telemedicine platform. This solution enables continuous monitoring of pets’ heart rhythms and overall health conditions, supporting early detection of potential health issues and promoting more proactive and preventive care approaches. TelmyVet is a Canada-based company that provides AI-powered, real-time health monitoring solutions for pets.

Major companies operating in the pet heart rhythm monitors market are Medtronic Plc, IDEXX Laboratories, Shenzhen Mindray Bio-Medical Electronics, Midmark Corporation, Antech Diagnostics, Nihon Kohden Corporation, Heal Force Bio-Meditech, Edan Instruments, Zomedica Corp., AliveCor Inc., Contec Medical Systems, Bionet Co Ltd., Schiller AG, Bionet America Inc., Fukuda Denshi, Digicare Biomedical Technology Inc., CardioComm Solutions Inc., VectraCor, New Gen Medical Systems.

North America was the dominating region in the pet heart rhythm monitors market in 2025. Asia Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the pet heart rhythm monitors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pet heart rhythm monitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pet heart rhythm monitors market consists of sales of multi parameter pet health monitoring devices, bluetooth enabled pet ecg recorders, and veterinary cardiac telemetry devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.